ROC-325

ROC-325 is a potent and orally active autophagy inhibitor with a strong anticancer activity. ROC-325 induces the deacidification of lysosomes, accumulation of autophagosomes, and disrupted autophagic flux. ROC-325 also induces renal cell carcinoma apoptosis[1].

Product Specifications

CAS Number

[1859141-26-6]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Apoptosis; Autophagy

Type

Reference compound

Related Pathways

Apoptosis; Autophagy

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/ROC-325.html

Purity

99.45

Solubility

DMSO : 4.55 mg/mL (ultrasonic; warming) |H2O : < 0.1 mg/mL

Smiles

O=C1C2=C(SC3=C1C=CC=C3)C(C)=CC=C2NCCN(CCNC4=CC=NC5=CC(Cl)=CC=C45)C

Molecular Formula

C28H27ClN4OS

Molecular Weight

503.06

Precautions

H302, H315, H319, H335

References & Citations

[1]Carew JS, et al. Disruption of Autophagic Degradation with ROC-325 Antagonizes Renal Cell Carcinoma Pathogenesis. Clin Cancer Res. 2017 Jun 1;23 (11) :2869-2879.